Abstract
The Pan American Health Organization presents this information sheet with recommendations on the use of molnupiravir addressed to health professionals. Molnupiravir is a prodrug that significantly inhibits SARS-CoV-2 replication. It is used for the treatment of mild and moderate COVID-19 in patients who are at high risk of complications, and has shown a significant reduction in the rate of hospitalization or death of patients with COVID-19.
–
Related posts:
WHO Requesting Information from China on Outbreak of Respiratory Disease in Children
Beware of dengue fever, immediately know the symptoms of dengue fever in children
"The Loud Sound of the Sun: NASA Scientists Share Discoveries"
VIDEO | A possible new branch of the Milky Way has been discovered - News by sources
